Literature DB >> 15065871

Tyrosine phosphorylation of the Janus kinase 2 activation loop is essential for a high-activity catalytic state but dispensable for a basal catalytic state.

Kiranam Chatti1, William L Farrar, Roy J Duhé.   

Abstract

The phosphorylation of an "activation loop" within protein kinases is commonly associated with establishing catalytic competence, and phosphorylation of the Tyr(1007) residue in the activation loop of Janus kinase 2 (JAK2) has been shown to be essential for intracellular propagation of cytokine-initiated signaling. We provide evidence for the presence of a basal activity state of JAK2, which was observed in the absence of activation loop phosphorylation. Phosphorylation of the JAK2 activation loop was essential for conversion to the high-activity state, characterized by high-efficiency ATP utilization during autophosphorylation. Mutagenesis of activation loop tyrosine residues Tyr(1007/1008) to phenylalanine residues impaired, but did not abolish, the enzyme's ability to autophosphorylate. The activation loop mutant JAK2 could also transphosphorylate an inactive JAK2 fragment coexpressed in Sf21 cells, providing evidence of exogenous substrate phosphorylation. The mutant enzyme remained in a basal activity state characterized by low-efficiency ATP utilization during autophosphorylation. Mutagenesis of a critical Lys(882) residue to a glutamate residue abolished all evidence of kinase activity, confirming that the observed activity of Tyr-to-Phe mutants was not due to another kinase. Our data are consistent with the proposal that JAK2 is an inefficient but active enzyme in the absence of activation loop phosphorylation and is capable of conversion to a high-activity state by autophosphorylation under physiological ATP concentrations. This theoretically precludes the need for an upstream activating kinase. The activation process of JAK2 may be envisioned as a multistate process involving at least two kinetically distinct states of activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15065871     DOI: 10.1021/bi036109b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Activation of JAK2-V617F by components of heterodimeric cytokine receptors.

Authors:  Anuradha Pradhan; Que T Lambert; Lori N Griner; Gary W Reuther
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

2.  Identification of a redox-sensitive switch within the JAK2 catalytic domain.

Authors:  John K Smith; Chetan N Patil; Srikant Patlolla; Barak W Gunter; George W Booz; Roy J Duhé
Journal:  Free Radic Biol Med       Date:  2012-01-15       Impact factor: 7.376

Review 3.  Molecular and neural mediators of leptin action.

Authors:  Scott A Robertson; Gina M Leinninger; Martin G Myers
Journal:  Physiol Behav       Date:  2008-04-13

4.  Phosphorylation of Y372 is critical for Jak2 tyrosine kinase activation.

Authors:  Jacqueline Sayyah; Kavitha Gnanasambandan; Sushama Kamarajugadda; Shigeharu Tsuda; Jennifer Caldwell-Busby; Peter P Sayeski
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

5.  A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation.

Authors:  Wei Wu; Xiao-Hong Sun
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

Review 6.  JAK redux: a second look at the regulation and role of JAKs in the heart.

Authors:  Mazen Kurdi; George W Booz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

Review 7.  The molecular regulation of Janus kinase (JAK) activation.

Authors:  Jeffrey J Babon; Isabelle S Lucet; James M Murphy; Nicos A Nicola; Leila N Varghese
Journal:  Biochem J       Date:  2014-08-15       Impact factor: 3.857

8.  Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.

Authors:  Banibrata Sen; Babita Saigal; Nila Parikh; Gary Gallick; Faye M Johnson
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

9.  Identification of tyrosine 972 as a novel site of Jak2 tyrosine kinase phosphorylation and its role in Jak2 activation.

Authors:  Issam McDoom; Xianyue Ma; Annet Kirabo; Kuang-Yung Lee; David A Ostrov; Peter P Sayeski
Journal:  Biochemistry       Date:  2008-07-18       Impact factor: 3.162

10.  Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.

Authors:  Vitalyi Senyuk; Ciro Roberto Rinaldi; Donglan Li; Francesca Cattaneo; Aleksandra Stojanovic; Fabrizio Pane; Xiaoping Du; Nadim Mahmud; Jerome Dickstein; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.